作者
Bas B Oude Munnink, David F Nieuwenhuijse, Mart Stein, Áine O’Toole, Manon Haverkate, Madelief Mollers, Sandra K Kamga, Claudia Schapendonk, Mark Pronk, Pascal Lexmond, Anne van der Linden, Theo Bestebroer, Irina Chestakova, Ronald J Overmars, Stefan van Nieuwkoop, Richard Molenkamp, Annemiek A van der Eijk, Corine GeurtsvanKessel, Harry Vennema, Adam Meijer, Andrew Rambaut, Jaap van Dissel, Reina S Sikkema, Aura Timen, Marion Koopmans
发表日期
2020/9/1
期刊
Nature Medicine
卷号
26
期号
9
页码范围
1405-1410
出版商
Nature Publishing Group US
简介
In late December 2019, a cluster of cases of pneumonia of unknown etiology were reported linked to a market in Wuhan, China. The causative agent was identified as the species Severe acute respiratory syndrome-related coronavirus and was named SARS-CoV-2 (ref. ). By 16 April the virus had spread to 185 different countries, infected over 2,000,000 people and resulted in over 130,000 deaths. In the Netherlands, the first case of SARS-CoV-2 was notified on 27 February. The outbreak started with several different introductory events from Italy, Austria, Germany and France followed by local amplification in, and later also outside, the south of the Netherlands. The combination of near to real-time whole-genome sequence analysis and epidemiology resulted in reliable assessments of the extent of SARS-CoV-2 transmission in the community, facilitating early decision-making to control local transmission of SARS …
引用总数
201920202021202220232024134110714013